Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |
DSM | Yes | Post-IPO Equity |
Vivo Capital | Yes | Post-IPO Equity |
Temasek Holdings | Yes | Post-IPO Equity |
Total | Yes | Post-IPO Equity |
Foris Ventures | - | Post-IPO Equity |
John Doerr | - | Post-IPO Equity |
Wei-Wu He | - | Post-IPO Equity |
TotalEnergies Ventures | - | Post-IPO Equity |
Biolding Investment | - | Post-IPO Equity |
Naxyris | - | Post-IPO Equity |
Total Gas & Power | - | Post-IPO Equity |
Cosan S.A. | - | Series D |
Procter & Gamble Company | - | Series D |
Khosla Ventures | - | Series C |
Kleiner Perkins | - | Series C |
TPG Growth | - | Series C |
Votorantim Novos Negocios | - | Series C |
DAG Ventures | - | Series B |